Kala Bio (KALA) Inventory Average (2018 - 2022)
Kala Bio (KALA) posted Inventory Average of $5.3 million for Q2 2022, down 44.93% sequentially from $9.6 million in Q1 2022, and down 35.19% YoY from $8.1 million in Q2 2021.
Kala Bio (KALA) Inventory Average (2018 - 2022) Analysis & Trends
Kala Bio has reported Inventory Average for 5 years, with the latest figure at $5.3 million in Q2 2022.
- Quarterly Inventory Average fell 35.19% year-over-year to $5.3 million in Q2 2022, while the trailing twelve-month figure through Jun 2022 was $5.3 million (down 35.19% YoY) and the FY2021 annual result came in at $6.9 million, up 40.41% from the prior year.
- Inventory Average slipped to $5.3 million in Q2 2022 per KALA's latest filing, from $9.6 million in the prior quarter.
- Over five years, Inventory Average peaked at $9.6 million in Q1 2022 and troughed at $2.5 million in Q4 2018.
- A 5-year average of $6.4 million and a median of $6.6 million in 2020 frame the typical range for Inventory Average.
- The sharpest annual moves came in 2019 and 2022: Inventory Average jumped 101.24% in 2019, then tumbled 35.19% in 2022.
- Over 5 years, Inventory Average stood at $2.5 million in 2018, then surged by 101.24% to $5.1 million in 2019, then advanced by 25.11% to $6.4 million in 2020, then grew by 28.04% to $8.2 million in 2021, then slumped by 35.43% to $5.3 million in 2022.
- According to Business Quant data, Inventory Average over the past three periods registered $5.3 million, $9.6 million, and $8.2 million for Q2 2022, Q1 2022, and Q4 2021 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 3.09 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 213.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 707.10 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 90.57 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 137.65 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 196.36 Mn |
| 10 | Kala Bio | 9.87 Mn | 9.87 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | 5.28 Mn |
| Mar 31, 2022 | 9.59 Mn |
| Dec 31, 2021 | 8.17 Mn |
| Sep 30, 2021 | 7.88 Mn |
| Jun 30, 2021 | 8.14 Mn |
| Mar 31, 2021 | 6.74 Mn |
| Dec 31, 2020 | 6.38 Mn |
| Sep 30, 2020 | 6.62 Mn |
| Jun 30, 2020 | 5.49 Mn |
| Mar 31, 2020 | 4.96 Mn |
| Dec 31, 2019 | 5.10 Mn |
| Sep 30, 2019 | 6.89 Mn |
| Jun 30, 2019 | 6.82 Mn |
| Mar 31, 2019 | 4.76 Mn |
| Dec 31, 2018 | 2.54 Mn |